These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6875818)
21. Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses. Beránková K; Szkutová M; Balíková M Forensic Sci Int; 2007 Aug; 170(2-3):94-9. PubMed ID: 17629428 [TBL] [Abstract][Full Text] [Related]
22. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model. Byron PR; Notari RE J Pharm Sci; 1976 Aug; 65(8):1140-4. PubMed ID: 978432 [TBL] [Abstract][Full Text] [Related]
23. Studies on the absorption of practically water-insoluble drugs following injection. I. Intramuscular absorption from water-immiscible oil solutions in rats. Hirano K; Ichihashi T; Yamada H Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):519-31. PubMed ID: 7273251 [No Abstract] [Full Text] [Related]
24. [Procaine penicillin; plasma concentration following intramuscular and subcutaneous administration; advantages of subcutaneous injection of an aqueous suspension procaine penicillin Novo]. SØBYE P; BULOW K Ugeskr Laeger; 1950 Apr; 112(17):571-8. PubMed ID: 15424971 [No Abstract] [Full Text] [Related]
25. Prediction of drug disposition kinetics in skin and plasma following topical administration. Guy RH; Hadgraft J J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948 [TBL] [Abstract][Full Text] [Related]
26. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models. Sjögren E; Thörn H; Tannergren C Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043 [TBL] [Abstract][Full Text] [Related]
27. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Mudaliar SR; Lindberg FA; Joyce M; Beerdsen P; Strange P; Lin A; Henry RR Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516 [TBL] [Abstract][Full Text] [Related]
28. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults. Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076 [TBL] [Abstract][Full Text] [Related]
29. In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems. Wu Z; Hassan D; Shaw JP J Pharm Pharmacol; 2013 Oct; 65(10):1429-39. PubMed ID: 24028610 [TBL] [Abstract][Full Text] [Related]
30. Drug metabolite concentration-time profiles: influence of route of drug administration. Houston JB; Taylor G Br J Clin Pharmacol; 1984 Apr; 17(4):385-94. PubMed ID: 6721984 [TBL] [Abstract][Full Text] [Related]
31. Influence of intravenous infusion duration on the tissue drug concentration profile. Uccellini DA; Raymond K; Morgan DJ J Pharmacokinet Biopharm; 1986 Jun; 14(3):323-34. PubMed ID: 3783449 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and size. Sigfridsson K; Palmer M Drug Dev Ind Pharm; 2014 Oct; 40(10):1318-24. PubMed ID: 23879245 [TBL] [Abstract][Full Text] [Related]
33. Unique approach to calculation of first-order absorption rate constants from blood or urine data. Pidgeon C; Pitlick WH J Pharmacokinet Biopharm; 1980 Apr; 8(2):203-14. PubMed ID: 7431223 [TBL] [Abstract][Full Text] [Related]
34. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of liposomal encapsulated buprenorphine suspension following subcutaneous administration to cats. Johnson RJ; Kerr CL; Enouri SS; Modi P; Lascelles BDX; Del Castillo JRE J Vet Pharmacol Ther; 2017 Jun; 40(3):256-269. PubMed ID: 27647259 [TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue. DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149 [TBL] [Abstract][Full Text] [Related]
39. A minimax approach to the single-point method of drug dosing. Bahn MM; Landaw EM J Pharmacokinet Biopharm; 1987 Jun; 15(3):255-69. PubMed ID: 3668803 [TBL] [Abstract][Full Text] [Related]
40. Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Berger M; Rodbard D Diabetes Care; 1989; 12(10):725-36. PubMed ID: 2693012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]